Pricing Log in Create free account

Clinuvel Pharmaceuticals Ltd. - Sponsored ADR (CUVL) vs Lexeo Therapeutics, Inc. (LXEO)

Clinuvel Pharmaceuticals Ltd. - Sponsored ADR and Lexeo Therapeutics, Inc. are both Biotechnology companies. Clinuvel Pharmaceuticals Ltd. - Sponsored ADR and Lexeo Therapeutics, Inc. are of similar size ($257.5M and $237.2M).

Valuation

Metric CUVL LXEO Biotechnology median
P/E — n/m 10.60
P/S — n/m 9.40
P/B — 1.05 2.13
Price to free cash flow — n/m 25.18
EV/EBITDA — n/m 0.66
EV/Sales — n/m 9.02
Earnings yield — (39.79%) (32.88%)
Free cash flow yield — (35.85%) (23.13%)

Profitability

Metric CUVL LXEO Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin — 0.00% 0.00%
Return on equity — (46.76%) (51.96%)
Return on assets — (40.50%) (46.06%)
Return on invested capital — (253.48%) 0.00%

Growth

Metric CUVL LXEO Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) — 39.81% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CUVL LXEO Biotechnology median
Debt to equity — 0.00 0.00
Current ratio — 13.89 4.97
Net debt to EBITDA — 1.67 1.01

Dividend

Metric CUVL LXEO Biotechnology median
Dividend yield 0.56% — 0.41%
Payout ratio — — —

Size

Metric CUVL LXEO Biotechnology median
Market cap 257.50m 237.23m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack